相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
Dirk Brehmer et al.
MOLECULAR CANCER THERAPEUTICS (2021)
PF-06939999, a potent and selective PRMT5 inhibitor, in patients with advanced or metastatic solid tumors: A phase 1 dose escalation study.
Jordi Rodon Ahnert et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Fragments: where are we now?
James Osborne et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling
Yukinori Tanaka et al.
FRONTIERS IN IMMUNOLOGY (2020)
438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
L L Siu et al.
ANNALS OF ONCOLOGY (2019)
PRMT5 is essential for B cell development and germinal center dynamics
Ludivine C. Litzler et al.
NATURE COMMUNICATIONS (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Determination of Affinity and Residence Time of Potent Drug-Target Complexes by Label-free Biosensing
John G. Quinn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q. Bonday et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W. Duncan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Konstantinos J. Mavrakis et al.
SCIENCE (2016)
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
Gregory V. Kryukov et al.
SCIENCE (2016)
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon et al.
CELL REPORTS (2016)
An Automated Microscale Thermophoresis Screening Approach for Fragment-Based Lead Discovery
Pawel Linke et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Prmt5 is required for germ cell survival during spermatogenesis in mice
Yanbo Wang et al.
SCIENTIFIC REPORTS (2015)
Preparation and Reactions of Heteroarylmethylzinc Reagents
Nadja M. Barl et al.
ORGANIC LETTERS (2014)
Fragment-based lead discovery grows up
Monya Baker
NATURE REVIEWS DRUG DISCOVERY (2013)
Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity
Meng-Chiao Ho et al.
PLOS ONE (2013)
Crystal structure of the human PRMT5:MEP50 complex
Stephen Antonysamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Revealing Atropisomer Axial Chirality in Drug Discovery
Steven R. LaPlante et al.
CHEMMEDCHEM (2011)
Fragment screening to predict druggability (ligandability) and lead discovery success
Fredrik N. B. Edfeldt et al.
DRUG DISCOVERY TODAY (2011)
Biosensor-based small molecule fragment screening with biolayer interferometry
Charles A. Wartchow et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Assessing Atropisomer Axial Chirality in Drug Discovery and Development
Steven R. LaPlante et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF
Pedro Andreu-Perez et al.
SCIENCE SIGNALING (2011)
Versatility of PRMT5-induced methylation in growth control and development
Vrajesh Karkhanis et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency
Wee-Wei Tee et al.
GENES & DEVELOPMENT (2010)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Protein Arginine Methylation in Mammals: Who, What, and Why
Mark T. Bedford et al.
MOLECULAR CELL (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Fragment-based lead discovery: leads by design
RAE Carr et al.
DRUG DISCOVERY TODAY (2005)
A novel WD repeat protein component of the methylosome binds Sm proteins
WJ Friesen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins
WJ Friesen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Synthesis and characterisation of a new class of stable S-adenosyl-L-methionine salts
A Morana et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
分享论文
